A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS

por Cousins, K., Sano, K., Singh, G., Aboelregal, N., Jeong, S., Ho, H., Krammer, F., Cunningham-Rundles, C.
Publicado 2021

OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls

por Gomez, J., Krammer, F., Mack, P., Rolfo, C., Rohs, N., Moore, A., King, J., Henschke, C., Yankelevitz, D., Shyr, Y., Taioli, E., Fontoura, B., Brody, R., Gerber, D., Minna, J., Bunn, P.A., Garcia-Sastre, A., Hirsch, F.
Publicado 2021

OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study

por Mack, P.C., Gomez, J.C., Rodilla, A., Carreño, J.M., Hsu, C.-Y., Rolfo, C.D., Meshulami, N., Moore, A., Brody, R., King, J.C., Treatman, J., Lee, S., Raskin, A., Srivastava, K., Gleason, C.R., Tcheou, J., Bielak, D., Acharya, R., Gerber, D.E., Rohs, N., Henschke, C.I., Yankelevitz, D.F., Simon, V., Minna, J.D., Bunn, P.A., García- Sastre, A., Krammer, F., Shyr, Y., Hirsch, F.R.
Publicado 2022